CRFB002ATR01-SALUTE, A randomized trial to compare the safety and efficacy of two ranibizumab dosing regimens in a Turkish cohort of patients with choroidal neovascularization secondary to AMD

---

ALAGÖZ N., ÇAKIR M., DÜNDAR H.

2010 - 2012

• Başlama Tarihi: Şubat 2010
• Bitiş Tarihi: Nisan 2012